Home
>
National Drug Code (NDC)
>
Methyldopa
Methyldopa - 0378-0611-01 - (methyldopa)
Drug Information of Methyldopa
| Product NDC: | 0378-0611 |
| Proprietary Name: | Methyldopa |
| Non Proprietary Name: | methyldopa |
| Active Ingredient(s): | 250 mg/1 & nbsp; methyldopa |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methyldopa
| Product NDC: | 0378-0611 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070076 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19850418 |
Package Information of Methyldopa
| Package NDC: | 0378-0611-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0611-01) |
NDC Information of Methyldopa
| NDC Code | 0378-0611-01 |
| Proprietary Name | Methyldopa |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0611-01) |
| Product NDC | 0378-0611 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methyldopa |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19850418 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | METHYLDOPA |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
